Thérapeutique
EASD 2014
Publié le 19 sep 2014
De nouveaux inhibiteurs de la DPP-4
I. GANTZ et coll. (États-Unis) - Effect of omarigliptin, a novel once-weekly DPP-4 inhibitor, in Japanese patients with type 2 diabetes: a placebo- and sitagliptin-controlled trial / N. INAGAKI et coll. (Japon) - Efficacy and safety of trelagliptin, a n